SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma

Emanuele Andreano; Giulia Piccini; Danilo Licastro; Lorenzo Casalino; Nicole V. Johnson; Ida Paciello; Simeone Dal Monego; Elisa Pantano; Noemi Manganaro; Alessandro Manenti; Rachele Manna; Elisa Casa; Inesa Hyseni; Linda Benincasa; Emanuele Montomoli; Rommie E. Amaro; Jason S McLellan; Rino Rappuoli.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-424451

Documentos relacionados

  1. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
  2. SARS-CoV-2 escape <i>in vitro</i> from a highly neutralizing COVID-19 convalescent plasma.
  3. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
  4. SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.
  5. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
  6. Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain.
  7. Exploring the immune evasion of SARS-CoV-2 variant harboring E484K by molecular dynamics simulations.
  8. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.
  9. Divergent Antibody Repertoires Found for Omicron versus Wuhan SARS-CoV-2 Strains Using Ig-MS.
  10. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.